Gemcitabine stimulates ROS generation in pancreatic cancer cells, resulting in constitutive NRF2 activation, leading to intrinsic gemcitabine resistance.28 Thus, gemcitabine metabolic enzymes might also possess certain roles in ROS generation and the NRF2/ARE axis. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.